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aspirin, beta-blockers and ACE-inhibitors markedly reduced it (OR= 1.1; 95% CI 0.63- 
1.9). Conclusions: MI pts with CRF are older, have more co-morbidities, present with 
higher Killip class and are more likely to experience complications and death. The 
underuse of evidence-based medicine may contribute to poor outcome and needs further 
evaluation. 
Clinical chrectarlstlcs, In-hospital procedures/therapies ,and complications 
Renal Failure No Renal Failure P 
n=132 n=1551 
Age,years (sd) 76 (11) 65 (14) <0.001 
Women 32 (24%) 419 (27%) <0.5 
Hypedension 83 (65%) 707 (46%) <0.001 
Diabetes 55 (43%) 477 (31%) <0.006 
Prior MI 54 (42%) 405 (27%) <0.001 
Kinip>l on 67 (51%) 357 (23%) <0.001 
admission 
Q wave MI 59 (45%) 962 (62%) <0.001 
Thrombolysis 20 (15%) 457 (30%) <0.001 
Coronary angio' 33 (26%) 703 (46%) <0.001 
PCI-in hospital 20 (16%) 434 (29%) <0.002 
Aspirin 106 (84%) 1479 (96%) <0.001 
ACE-inhibitors 49 (51%) 887 (63%) <0.01 
Beta-blockers 53 (54%) 1025 (74%) <0.001 
Heart failure 44 (36%) 308 (21%) <0.001 
Atrial fibrillation 20 (16%) 132 (9%) <0.009 
Sepsis 12 (9%) 42 (3%) <0.001 
Acute renal failure 80 (63%) 97 (6%) <0.001 
1145-46 Chlamydia pneumoniae Infection and Classic Risk 
Factors in the Prediction of Acute Myocardial Infarction 
Kunihire Kinjo, Hiroshi Sate, Hideyuki Sate, Issei Shiotani, Yozo Ohnishi, Daisaku 
Nakatani, Hiroya Mizuno, Eiji Hishida, Yasuhiko Matsu-ura, Yoshiyuki Kijima, Masetsugu 
Hori, Osaka University Graduate School of Medicine, Suita, Japan. 
Background: Several seroepidemiologic studies have shown an association between 
Chlamydia pneumoniae infection and the presence of coronary artery disease (CAD) or 
the risk for acute coronary events. Since it has been suggested that C. pneumoniae 
infection can interact with several classic risk factors of CAD, C. pneumoniae infection 
may enhance the effect of classic risk factors on the onset of AML 
Methods: The case group consisted of 607 patients with AMI. Control group consisted of 
275 subjects without history of definite or suspected coronary heart disease who under- 
went medical examination. Total subjects were tested for specific C. pneumoniae IgG 
and IgA antibodies by ELISA and were also assessed for classic risk factors, i.e., age, 
sex, obesity, diabetes mellitus, hypertension, hyperlipidemia, Iow-HDL cholesterol, and 
smoking habit. Logistic regression model was used to identify an independent predictor 
of the onset of AMI. 
Results: Prevalence of seropositivity for IgA antibody in the case group was significantly 
higher than in the control group (29% vs. 15%; p<0.01), but prevalence of seropositivity 
for IgG antibody was similar in the both groups (17% vs. 16%; p=0.73). In all study popu- 
lations, seropositivity for IgA antibody was not an independent predictor of the onset of 
AMI by multivariate analysis (odds ratio, 1.49; 95% confidence interval, 0.90-2.45). How- 
ever, subgroup analysis revealed that prevalence of seropositivity for IgA antibody was 
an independent predictor of the onset of AMI in patients of <60 years (2.39; 1.11-5.11), 
male patients (1.86; 1.09-3.17), patients with hyperlipidemia (2.42; 1.14-5.12), and smok- 
ers (1.85; 1.02-3.34). 
Conclusion: C. pneumoniae infection enhances the effect of classic risk factors on the 
onset of AMI, especially in patients with hyperlipidemia and in smokers. Thus, measure- 
ment of IgA antibody to C pneumoniae may increase the predictive value of coronary risk 
factors for the onset of AMI. 
1145-47 Ef fect  of Three-Month Antimicrobial Treatment With 
Clarithromycin in Acute Non-Q Wave Coronary 
Syndrome 
Juha P. Sinisalo, Kimmo J. Mattila, Ville Valtonen, Olli Anttonen, Jukka Juvonen, John 
Melin, Helena Vuorinen-Markkola, Markku S. Nieminen, CLARIFY-study group, Helsinki 
University Central Hospital, Helsinki, Finland. 
Background: Coronary artery disease is accepted to be an inflammatory disease and 
infections have been postulated as one of the reasons for this inflammation. We investi- 
gated whether the antibiotic clarithromycin would reduce morbidity and mortality in 
patients presenting with an acute non-Q-wave coronary syndrome. 
Methods: 148 patients with an acute non-Q-wave infarction or unstable angina were ran- 
domly assigned to receive double-blind treatment with either clarithromycin or placebo 
(74 patients in both groups) for 3 months. The primary endpoint was occurrence of the 
composite of death, myocardial infarction, or refractory isehemia during the treatment; 
the secondary endpoint was occurrence of any cardiovascular event during the whole fol- 
low up (average 555 days, range 138 to 924 days). 
Results: There was a trend towards fewer patients meeting the endpoint criteria in the 
clarithromycin group when compared with placebo group (11 vs. 19 patients, respec- 
tively; Cox regression analysis risk ratio 0.54; 95% CI 0.25-1.14; p=0.10) during the 3 
months medication. By the end of the whole follow up period, 16 patients in the clarithro- 
mycin group and 27 patients in the placebo group experienced any cardiovascular event 
ABSTRACTS-  Myocard ia l  In fa rc t ion  and  I schemia  317A 
(risk ratio 0.49; 95% CI 0.26-0.92; p=0.03), 
Conclusion: Clarithromycin seems to reduce the risk of ischemic cardiovascular events 
in patients presenting with an acute non-Q-wave infarction or unstable angina. No signs 
of this effect becoming smaller were observed during the follow up. 
K~4= -I.lkter plgl ~ CmllllMi~e i~,r tlwl 
dm'k~ tile lalow uB. 
L 
: ' 
O 200 600 1000 
Days from randomlsation 
1145-48 Deterioration of Risk Factors Is Not a Major Determinant 
of Coronary Events in Depressive Patients With Acute 
Myocardial Infarction 
Issei Shiotani, Hiroshi Sate, Hideyuki Sate, Kunihiro Kinjo, Daiseku Nakatani, Hiroya 
Mizuno, Eiji Hishida, Yozo Ohnishi, Seiki Nagata, Noritake Houki, Masatsugu Hod, 
Osaka University, Suita, Japan. 
Background: It has been reported that depressive symptoms increase a risk for cardiac 
events and worsen clinical outcomes both in healthy subjects and in patients with acute 
myocardial infarction (AMI). However, mechanisms in which depressive symptoms cause 
coronary events have not been elucidated. The aim of the present study is to test a 
hypothesis that depression deteriorates coronary risk factors and hence increases a risk 
for coronary event in normal subjects and in patients with AMI. Methods: Of consecutive 
1229 patients with AMI were registered to Osaka Acute Coronary Insufficiency Study 
from September 1999 through January 2001, 854 patients who survived and discharged 
from hospital without any clinical disabilities were enrolled in this study (670 men; mean 
age 64±11 y.o). Healthy subjects were selected from outpatient clinic for medical 
checkup (n=1083; 627 men; mean age 49±10 y.o). Depression was assessed using the 
Zung Self-Rating Depression Scale (SDS). Subject with a score of 40 or higher was diag- 
nosed as depression, Results: The SDS score identified depression in 276 healthy sub- 
jects (25.5%) and 361 patients (42.3%) with AMI (p<0.0001). Prevalence of depression 
was associated with women (p=0.071) and young population (p=0,065) in healthy sub- 
jects, however was not associated with other coronary risk factors. Whereas in patients 
with AMI, prevalence of depression was not dependent of age, gender, severity of myo- 
cardial infarction (Killip class, number of disease vessels, peak-CK), and coronary risk 
factors except diabetes meUitus. Multiple logistic regression analyses showed that 
depressive status in patients with AMI was significantly associated with 1-year cardiac 
events (odds ratio 1.45, 96%CI 1.03-2.04, p=0.036), after controlling coronary risk fac- 
tors, e.g. diabetes mellitus, hypertension, hypercholesterolemia, smoking, gout, and obe- 
sity. Conclusion: Depression does not deteriorate coronary risk factors in healthy 
subjects. Furthermore, depression is an independent predictor of 1-year cardiac event 
after controlling risk factors, indicating that deterioration of risk factors may not be a 
major determinant of coronary events in depressive population. 
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1146-31 BNP Identifies Patients With Optimal Reperfusion After 
PTCA for Acute Myocardial Infarction 
Patrick Jourdain, Francois Funck, Michel Be,orini, Nils Guillard, Jean Loiter, Bernard 
Thehault, Michel Desnos, Denis Duboc, H6pital Rene Dubos, Pentoise, France. 
Background : Brain Natriuretic Peptide evaluate the effect of revascularization on (BNP) 
is an hormone synthesized by ventricular myocytes, which has been reported to be 
increased during acute myOCardial infarction (AMI). In order to the level of BNP, we mea- 
sured its concentration in 60 consecutive patients hospitalized for AMI. They were classi- 
fied into Group A : patients in which PTCA restore Timi III flow in the infarct-related artery 
(N = 54), and Group B (N=6) : patients in which no successful PTCA was performed. 
Methods: BNP was measured every 30 minutes during the first 4 hours after admission 
and every 2 hours during the next 12 hours. BNP was measured using the IRMA test (Cis 
Bio laboratories), Reperfusion was performed by angioplasty with direct stenting and was 
effective in all 240 ± 30 minutes after the onset of chest pain. 
Results: in Group A , average BNP measured level fell 30 minutes after restoration of 
TIMI 3 flow in the infarct-related artery. The relative variation of the mean level after 
PTCA was - 58 % ± 16%, p < 0,0001). ~n Group B there was no significant variation of 
BNP. 
Conclusion: Decrease in the level of plasma BNP appears to be a clinically relevant bio- 
logical marker of reperfusion during acute AMI. 
